DocDollars

Otsuka America Pharmaceutical, Inc.

MD · United States · Reporting entity ID 100000010723

Total reported 2019–2025
$71.6M
#131 of 2,960 reporting companies — 0.1% of all reported industry payments
$71.6M in general payments across 894,361 records.

How it breaks down

General payments $71,605,244

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Otsuka America Pharmaceutical, Inc. reported $71.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #131 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 894,361 general payment records were filed.

Common questions about Otsuka America Pharmaceutical, Inc.

How much has Otsuka America Pharmaceutical, Inc. paid US doctors?

Otsuka America Pharmaceutical, Inc. reported $71,605,244 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $71,605,244 in general payments.

How does Otsuka America Pharmaceutical, Inc. rank among drug and device companies?

It ranks #131 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Otsuka America Pharmaceutical, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.